Answers are grounded in this paper and cite their sources.
Diagnostic role of maternal serum prokineticin-1 indicates adverse outcomes in pregnancies affected by preeclampsia, suggesting its use in prediction models.
Maternal serum PROK-1 was elevated in PE and correlated with disease severity and adverse perinatal outcomes. Although inadequate as a stand-alone marker, PROK-1 may complement existing angiogenic biomarkers in multimarker prediction models.
No takes yet. Share an insight, caveat, or question.
Özkan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: